The P2Y


Journal

Cellular and molecular life sciences : CMLS
ISSN: 1420-9071
Titre abrégé: Cell Mol Life Sci
Pays: Switzerland
ID NLM: 9705402

Informations de publication

Date de publication:
15 Sep 2022
Historique:
received: 18 03 2022
accepted: 04 09 2022
revised: 22 08 2022
entrez: 15 9 2022
pubmed: 16 9 2022
medline: 20 9 2022
Statut: epublish

Résumé

The cytoprotective ATP receptor P2Y

Identifiants

pubmed: 36107259
doi: 10.1007/s00018-022-04548-z
pii: 10.1007/s00018-022-04548-z
pmc: PMC9476423
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Inflammasomes 0
Interleukin-1 0
P2RY11 protein, human 0
RNA, Messenger 0
Receptors, Interleukin-1 0
Receptors, Purinergic P2 0
Receptors, Tumor Necrosis Factor, Type II 0
Suppressor of Cytokine Signaling Proteins 0
Vascular Endothelial Growth Factor A 0
Adenosine Triphosphate 8L70Q75FXE
Cyclic AMP E0399OZS9N
Protein Kinase C EC 2.7.11.13
Cyclic Nucleotide Phosphodiesterases, Type 4 EC 3.1.4.17
Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

519

Subventions

Organisme : Austrian Science Fund
ID : P 33640-B

Informations de copyright

© 2022. The Author(s).

Références

PLoS One. 2011;6(9):e24671
pubmed: 21935436
Nat Rev Immunol. 2011 Mar;11(3):201-12
pubmed: 21331080
J Biol Chem. 1997 Dec 19;272(51):31969-73
pubmed: 9405388
J Pharmacol Exp Ther. 2010 Jan;332(1):238-47
pubmed: 19815812
Biochem J. 1996 Sep 1;318 ( Pt 2):425-36
pubmed: 8809029
Mol Endocrinol. 2006 Jul;20(7):1587-96
pubmed: 16543409
Purinergic Signal. 2021 Dec;17(4):633-648
pubmed: 34476721
Biochem Pharmacol. 2021 May;187:114361
pubmed: 33309519
Mol Cell Biol. 2006 Sep;26(17):6333-46
pubmed: 16914720
Sci Signal. 2020 Sep 29;13(651):
pubmed: 32994212
Infect Immun. 2003 Jan;71(1):365-73
pubmed: 12496186
Cells. 2021 May 04;10(5):
pubmed: 34064383
Exp Cell Res. 2018 Nov 15;372(2):168-177
pubmed: 30287142
Immunol Rev. 2011 Sep;243(1):136-51
pubmed: 21884173
Am J Physiol Cell Physiol. 2020 May 1;318(5):C832-C835
pubmed: 32159362
Sci STKE. 2003 Feb 25;2003(171):re3
pubmed: 12606705
Int J Mol Sci. 2020 Jul 22;21(15):
pubmed: 32707869
Nature. 2014 May 15;509(7500):310-7
pubmed: 24828189
Biochem Biophys Res Commun. 2013 Oct 25;440(3):443-8
pubmed: 24099776
Br J Pharmacol. 2020 Jun;177(11):2413-2433
pubmed: 32037507
Cell Mol Life Sci. 2011 Dec;68(23):3823-41
pubmed: 21744067
Blood. 2003 Apr 1;101(7):2620-7
pubmed: 12411307
Immunol Rev. 2018 Jan;281(1):197-232
pubmed: 29248002
Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2835-40
pubmed: 25730877
J Clin Invest. 1988 Oct;82(4):1219-24
pubmed: 2971671
Trends Pharmacol Sci. 2012 Feb;33(2):64-78
pubmed: 22100304
Trends Pharmacol Sci. 2018 Sep;39(9):798-811
pubmed: 30054020
Cell Signal. 2009 Nov;21(11):1706-15
pubmed: 19632320
Purinergic Signal. 2016 Sep;12(3):427-37
pubmed: 27246167
Cell Immunol. 1985 Jan;90(1):226-33
pubmed: 3917862
Am J Pathol. 2006 Dec;169(6):2199-208
pubmed: 17148681
Circ Res. 2008 Oct 24;103(9):916-8
pubmed: 18818406
Br J Pharmacol. 2021 Apr;178(7):1541-1555
pubmed: 33463722
Blood. 2005 Dec 1;106(12):3860-6
pubmed: 16118322
Semin Thromb Hemost. 2005 Apr;31(2):217-33
pubmed: 15852225
Front Immunol. 2013 Nov 22;4:398
pubmed: 24319446
Int J Mol Sci. 2019 Oct 15;20(20):
pubmed: 31618941
Cell Rep. 2019 Apr 2;27(1):1-10.e4
pubmed: 30943393
J Biol Chem. 2015 Jun 5;290(23):14717-28
pubmed: 25918170
Am J Pathol. 2013 Jan;182(1):10-20
pubmed: 23159950
Nat Rev Immunol. 2020 Jun;20(6):355-362
pubmed: 32376901
Biochem Pharmacol. 2005 Jul 15;70(2):266-74
pubmed: 15913566
J Biol Chem. 1990 Jun 25;265(18):10232-7
pubmed: 2354999
Cell Mol Life Sci. 2013 May;70(10):1673-4
pubmed: 23475064
Adv Exp Med Biol. 2017;1051:107-122
pubmed: 29134605
Cells. 2019 Oct 14;8(10):
pubmed: 31615122
PLoS One. 2015 Mar 13;10(3):e0120855
pubmed: 25768730
Blood. 1991 Apr 15;77(8):1627-52
pubmed: 1826616
Mol Pharmacol. 2003 Jul;64(1):104-12
pubmed: 12815166
J Immunol. 1998 Apr 1;160(7):3513-21
pubmed: 9531313
J Biol Chem. 1990 Dec 25;265(36):22499-505
pubmed: 2148319
Nucleic Acids Res. 2022 Jan 7;50(D1):D1282-D1294
pubmed: 34718737
Blood. 2012 Aug 9;120(6):1290-8
pubmed: 22723552
Front Immunol. 2014 Feb 19;5:58
pubmed: 24600449
Biochem Pharmacol. 2004 Nov 15;68(10):1995-2002
pubmed: 15476670
J Mol Cell Cardiol. 2000 Nov;32(11):1955-67
pubmed: 11040101
Sci Rep. 2016 Sep 02;6:32602
pubmed: 27586846
Br J Pharmacol. 1997 May;121(2):338-44
pubmed: 9154346
Front Immunol. 2019 Aug 09;10:1870
pubmed: 31447857
Sci STKE. 2006 May 23;2006(336):pe22
pubmed: 16720840

Auteurs

Dominik Klaver (D)

Immunotherapy Unit, Department of Urology, Medical University of Innsbruck, Innrain 66a, 6020, Innsbruck, Austria.

Hubert Gander (H)

Immunotherapy Unit, Department of Urology, Medical University of Innsbruck, Innrain 66a, 6020, Innsbruck, Austria.

Gabriele Dobler (G)

Immunotherapy Unit, Department of Urology, Medical University of Innsbruck, Innrain 66a, 6020, Innsbruck, Austria.

Andrea Rahm (A)

Immunotherapy Unit, Department of Urology, Medical University of Innsbruck, Innrain 66a, 6020, Innsbruck, Austria.

Martin Thurnher (M)

Immunotherapy Unit, Department of Urology, Medical University of Innsbruck, Innrain 66a, 6020, Innsbruck, Austria. martin.thurnher@i-med.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH